140 related articles for article (PubMed ID: 29223988)
21. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
Gowin K; Langlais BT; Kosiorek HE; Dueck A; Millstine D; Huberty J; Eckert R; Mesa RA
Cancer Med; 2020 Dec; 9(24):9445-9453. PubMed ID: 33140580
[TBL] [Abstract][Full Text] [Related]
22. Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97).
Felser S; Rogahn J; Hollenbach L; Gruen J; le Coutre P; Al-Ali HK; Schulze S; Muegge LO; Kraze-Kliebhahn V; Junghanss C
Cancer Med; 2023 Sep; 12(17):18235-18245. PubMed ID: 37559463
[TBL] [Abstract][Full Text] [Related]
23. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Scherber RM; Kosiorek HE; Senyak Z; Dueck AC; Clark MM; Boxer MA; Geyer HL; McCallister A; Cotter M; Van Husen B; Harrison CN; Mesa RA
Cancer; 2016 Feb; 122(3):477-85. PubMed ID: 26670597
[TBL] [Abstract][Full Text] [Related]
24. Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms.
Tolstrup Larsen R; Tang LH; Brochmann N; Meulengracht Flachs E; Illemann Christensen A; Hasselbalch HC; Zwisler AD
Eur J Haematol; 2018 Jun; 100(6):550-559. PubMed ID: 29464777
[TBL] [Abstract][Full Text] [Related]
25. High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer.
Roerink SH; de Ridder M; Prins J; Huijbers A; de Wilt HJ; Marres H; Repping-Wuts H; Stikkelbroeck NM; Timmers HJ; Hermus AR; Netea-Maier RT
Acta Oncol; 2013 Jan; 52(1):128-37. PubMed ID: 23101467
[TBL] [Abstract][Full Text] [Related]
26. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
Mesa RA; Niblack J; Wadleigh M; Verstovsek S; Camoriano J; Barnes S; Tan AD; Atherton PJ; Sloan JA; Tefferi A
Cancer; 2007 Jan; 109(1):68-76. PubMed ID: 17123268
[TBL] [Abstract][Full Text] [Related]
27. Distress thermometer for preoperative screening of patients with oral squamous cell carcinoma.
Schell JT; Petermann-Meyer A; Kloss-Brandstätter A; Bartella AK; Kamal M; Hölzle F; Lethaus B; Teichmann J
J Craniomaxillofac Surg; 2018 Jul; 46(7):1111-1116. PubMed ID: 29789211
[TBL] [Abstract][Full Text] [Related]
28. Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research.
Eckert R; Huberty J; Gowin K; Mesa R; Marks L
Integr Cancer Ther; 2017 Dec; 16(4):439-450. PubMed ID: 27458250
[TBL] [Abstract][Full Text] [Related]
29. Self-reported distress in patients with ovarian cancer: is it related to disease status?
Ploos van Amstel FK; van Ham MA; Peters EJ; Prins JB; Ottevanger PB
Int J Gynecol Cancer; 2015 Feb; 25(2):229-35. PubMed ID: 25594140
[TBL] [Abstract][Full Text] [Related]
30. Management of MPN beyond JAK2.
Harrison CN; Garcia NC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):348-54. PubMed ID: 25696878
[TBL] [Abstract][Full Text] [Related]
31. How much psychological distress is experienced at home by patients with palliative care needs in Germany? A cross-sectional study using the Distress Thermometer.
Küttner S; Wüller J; Pastrana T
Palliat Support Care; 2017 Apr; 15(2):205-213. PubMed ID: 27456895
[TBL] [Abstract][Full Text] [Related]
32. Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
Kaifie A; Isfort S; Gattermann N; Hollburg W; Klausmann M; Wolf D; Maintz C; Hänel M; Goekkurt E; Göthert JR; Platzbecker U; Geer T; Parmentier S; Jost E; Serve H; Ehninger G; Berdel WE; Brümmendorf TH; Koschmieder S;
Ann Hematol; 2016 Sep; 95(9):1399-410. PubMed ID: 27334946
[TBL] [Abstract][Full Text] [Related]
33. Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.
Anderson LA; James G; Duncombe AS; Mesa R; Scherber R; Dueck AC; de Vocht F; Clarke M; McMullin MF
Am J Hematol; 2015 Oct; 90(10):864-70. PubMed ID: 26113113
[TBL] [Abstract][Full Text] [Related]
34. Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study.
Troy JD; de Castro CM; Pupa MR; Samsa GP; Abernethy AP; LeBlanc TW
J Natl Compr Canc Netw; 2018 Mar; 16(3):267-273. PubMed ID: 29523665
[No Abstract] [Full Text] [Related]
35. Pain, fatigue, disturbed sleep and distress comprised a symptom cluster that related to quality of life and functional status of lung cancer surgery patients.
Lin S; Chen Y; Yang L; Zhou J
J Clin Nurs; 2013 May; 22(9-10):1281-90. PubMed ID: 23574291
[TBL] [Abstract][Full Text] [Related]
36. Patients with oesophageal cancer report elevated distress and problems yet do not have an explicit wish for referral prior to receiving their medical treatment plan.
Jacobs M; Anderegg MC; Schoorlemmer A; Nieboer D; Steyerberg EW; Smets EM; Sprangers MA; van Berge Henegouwen MI; de Haes JC; Klinkenbijl JH
Psychooncology; 2017 Apr; 26(4):452-460. PubMed ID: 27246192
[TBL] [Abstract][Full Text] [Related]
37. Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
Langlais BT; Geyer H; Scherber R; Mesa RA; Dueck AC
Leuk Lymphoma; 2019 Feb; 60(2):402-408. PubMed ID: 30033837
[TBL] [Abstract][Full Text] [Related]
38. JAK2-v617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms.
Duletić AN; Dekanić A; Hadzisejdić I; Kusen I; Matusan-Ilijas K; Grohovac D; Grahovac B; Jonjić N
Coll Antropol; 2012 Sep; 36(3):859-65. PubMed ID: 23213945
[TBL] [Abstract][Full Text] [Related]
39. Refinement of the distress management problem list as the basis for a holistic therapeutic conversation among UK patients with cancer.
Brennan J; Gingell P; Brant H; Hollingworth W
Psychooncology; 2012 Dec; 21(12):1346-56. PubMed ID: 21905157
[TBL] [Abstract][Full Text] [Related]
40. Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.
Benton CB; Tanaka M; Wilson C; Pierce S; Zhou L; Cortes J; Kantarjian H; Verstovsek S
Leuk Res; 2015 Apr; 39(4):419-23. PubMed ID: 25687833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
